ACT Biotech, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2008-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.actbiotech.com
A Study of Telatinib in Combination With Chemotherapy in Subjects With Advanced Gastric Cancer
- First Posted Date
- 2009-08-06
- Last Posted Date
- 2012-02-08
- Lead Sponsor
- ACT Biotech, Inc
- Target Recruit Count
- 48
- Registration Number
- NCT00952497
- Locations
- 🇺🇸
UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, United States
🇪🇸Hospital Universitario 12 de Octubre, Madrid, Spain
🇺🇸Central Georgia Cancer Care, P.C., Macon, Georgia, United States
© Copyright 2025. All Rights Reserved by MedPath